Navigation Links
Recent breakthroughs in common adult leukemia highlighted in New England Journal of Medicine

When the most common adult leukemia in the United States was last reviewed by the New England Journal of Medicine (NEJM) in 1995, it was seen through the eyes of theories that dated back to the 1960s. As such, the journal recently invited three of the world's foremost experts on chronic lymphocytic leukemia (CLL) to write an authoritative update covering the transformation in the scientific community's knowledge of CLL that has occurred over the past decade. The review appears in the February 24 issue.

Two of the expert authors are with the North Shore-Long Island Jewish (LIJ) Health System (www.northshorelij.com): Nicholas Chiorazzi, MD, director and CEO of the Institute for Medical Research at North Shore-LIJ in Manhasset, NY, who also serves as Professor of Medicine at New York University School of Medicine, and Kanti R. Rai, MB, BS, investigator at the Institute for Medical Research, chief of hematology-oncology at LIJ Medical Center in New Hyde Park, NY, and the Joel Finkelstein Cancer Foundation Professor of Medicine at Albert Einstein College of Medicine. The third author, Manlio Ferrarini, MD, is with the National Institute for Cancer Research in Genoa, Italy (Istituto Nazionale per la Ricerca sul Cancro, Genova, Italia).

"Previous theories about the development and progression of chronic lymphocytic leukemia require revision. With new molecular and protein markers now identified, patients with features that portend poor outcomes may soon be treated earlier and more effectively," said Dr. Chiorazzi.

"Once these new prognostic markers are clinically available to doctors, and after large-scale trials testing early intervention are completed, the 'watchful waiting' practice may be abandoned in many cases," said Dr. Rai, who treats many CLL patients. "New and upcoming discoveries made collectively by us and many other scientists around the world may alter the natural history of this currently incurable leukemia," he added.

A decade
'"/>

Source:North Shore Long Island Jewish Health System


Page: 1 2

Related biology news :

1. Recent, rapid climate change is driving evolution of animal species
2. Recently discovered species gain protection
3. U-M scientists find genes that control growth of common skin cancer
4. Iron exporter revealed that may explain common human disorder
5. Does vitamin C help prevent or treat the common cold? Maybe not, after all.
6. High-powered gene profiles provide clues to genes involved in common form of lung cancer
7. Doctors should stop prescribing antibiotics for the common cold, review advises
8. Most common lung cancers may begin in newly discovered cells
9. Ibruprofen and other commonly used painkillers for treating inflammation may increase the risk of heart attack
10. Toxic flood lifts lid on common urban pollution problem
11. Scientists use gene transfer technology and common virus to block neuropathic pain in animals
Post Your Comments:
(Date:6/19/2013)... area network in Tanzania is playing a vital role ... move west in response to climate and environmental changes, ... York., Using data on savannah birds from the Tanzanian ... distributions over recent decades - the researchers found that ... they move to areas further west where dry seasons ...
(Date:6/19/2013)... International Science Consortium (PISC) is extremely disappointed that ... has upheld a decision that requires Dow Benelux ... rats. The study will use approximately 1160 animals ... to the substance dipropylene glycol methyl ether acetate ... Community,s Regulation on the Registration, Evaluation, Authorisation and ...
(Date:6/19/2013)... of researchers at the University of Pittsburgh has ... of HIV, that could be potential treatments for ... resistance. These new agents are quite small, making ... was published in the June 2013 issue of ... , The first of many probable applications will ...
Breaking Biology News(10 mins):Protected areas provide African birds with stepping stones to survival 2HIV-derived antibacterial shows promise against drug-resistant bacteria 2
... seaports around the world are unprepared for the potentially ... according to a new Stanford University study. In ... the Stanford team found that most officials are unsure ... levels and more frequent Katrina-magnitude storms, which scientists say ...
... TORONTO, ON Childhood physical abuse is associated with ... chronic fatigue syndrome, fibromyalgia and multiple chemical sensitivities among ... researchers. The research will be published in this month,s ... Trauma . "Women who reported they had been ...
... This release is available in German . ... reproductive strategy for the individual but it can drive the ... biologist Daniel Rankin from the University of Zurich has demonstrated ... have long debated whether the behavior of the individual is ...
Cached Biology News:Seaports need a plan for weathering climate change, Stanford researchers say 2Seaports need a plan for weathering climate change, Stanford researchers say 3Aggressive male mating behavior can endanger species 2
(Date:6/19/2013)... A new look at “big glass” and ... will highlight technical sessions at SPIE Photomask Technology ... 33rd year, the three-day event is the industry’s largest ... approximately 100 technical presentations and numerous networking lunches and ... optics and photonics , the meeting will be held ...
(Date:6/18/2013)... (PRWEB) June 18, 2013 Tabletop SEMs ... size SEMs but have limited performance and capability such ... Full size SEMs would normally provide better imaging performance ... to operate and have a higher cost of maintenance. ... the gap between these two types of SEM product, ...
(Date:6/18/2013)... In support of Swiss contributions to ... of Switzerland in New York is pleased to welcome ... PlanetSolar , to Manhattan. PlanetSolar is in New ... tour with scientists on board from the University of ... exclusively on energy from the sun and eliminates the ...
(Date:6/18/2013)... June 18, 2013 Demanding industrial and ... engineered of synthetic Sapphire and Glass Ball Lenses, now ... Swiss Jewel Company , of Philadelphia , PA. ... and collimating the light beams without the need for ... and natural durability (9 mohs) make it the ideal ...
Breaking Biology Technology:‘Big Glass’ and Visions for the Future are on the Program for SPIE Photomask Technology 2‘Big Glass’ and Visions for the Future are on the Program for SPIE Photomask Technology 3Nanounity Introduces the Pemtron Range of Compact Scanning Electron Microscopes 2Nanounity Introduces the Pemtron Range of Compact Scanning Electron Microscopes 3Switzerland’s MS Tûranor PlanetSolar, the World’s Largest Solar Boat, Arrives in New York City 2Switzerland’s MS Tûranor PlanetSolar, the World’s Largest Solar Boat, Arrives in New York City 3Switzerland’s MS Tûranor PlanetSolar, the World’s Largest Solar Boat, Arrives in New York City 4Swiss Jewel Introduces the Crown Jewels of Fiber-Optic Connectors 2
... and professionals to share ... FARMINGTON HILLS, Mich., Oct. 18 BiotechWatch, ... information on the,biotechnology sector has expanded its offerings ... launch of The Biotech Forums. Within,The Biotech Forums, ...
... HOPKINTON, Mass., Oct. 18 Alseres,Pharmaceuticals, Inc. ... Dr. Frank Bobe,Executive Vice President and Chief ... presenting at Windhover Information,s 2nd,Annual Therapeutic Area ... Bobe will be presenting an overview on ...
... Oriental,Bioengineering, Inc. (NYSE: AOB ) ("AOBO"), a ... products, today,announced that it has completed the acquisition ... price for this all,cash transaction is approximately USD$36.5 ... immediately upon closing. Boke is located in ...
Cached Biology Technology:BiotechWatch Launches The Biotech Forum 2Alseres Pharmaceuticals, Inc. to Present at Windhover's Therapeutic Area Partnerships Conference 2American Oriental Bioengineering Completes Acquisition of Guangxi Boke Pharmaceutical Company Ltd. 2American Oriental Bioengineering Completes Acquisition of Guangxi Boke Pharmaceutical Company Ltd. 3
Rabbit polyclonal to Phosphothreonine-Proline / Phosphoserine-Proline ( Abpromise for all tested applications)....
Mouse monoclonal [7C6] to Bcr-abl ( Abpromise for all tested applications). SwissProtID: P11274...
Chicken polyclonal to Thioredoxin domain containing 9 ( Abpromise for all tested applications). Antigen: Full length protein (Human) Entrez Gene ID: 10190 Swiss Protein ID: O14530...
Mouse anti-IkBa/MAD-3 Class: Antibody Product Group: Signalling molecules and phospho-specific Antibody...
Biology Products: